IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Spruce Street Capital LP

Portfolio Profile

CIK: 0002050194 | NEW YORK, NY

Investment Profile

Style

Deep Value

Turnover

High

Orientation

Concentrated trader
$509.7M
AUM
30
Positions
70.24%
Top 10 Conc.
96.58%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Kiniksa Pharmaceuticals Intl(KNSA)918,070$58.7M11.52%
2Relay Therapeutics Inc(RLAY)2,984,125$55.8M10.95%
3LB Pharmaceuticals Inc(LBRX)1,376,159$44.7M8.76%
4Relmada Therapeutics Inc(RLMD)6,391,328$44.2M8.68%
5Alto Neuroscience Inc(ANRO)1,353,047$35.7M7.01%

Sector Allocation

Latest filing, equity positions only

Healthcare95.2% · $485.2M
Unclassified4.8% · $24.5M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.78%95.2%-3.58%
Unclassified1.22%4.8%+3.58%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$302.7M | 27 pos.
$415.9M | 28 pos.
$509.7M | 30 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

5
New
3
6
Dianthus Therapeutics Inc(DNTH)
354,816
$34.6M
6.79%
7Alkermes PLC(ALKS)543,876$28.5M5.59%
8Savara Inc(SVRA)3,452,576$21.3M4.17%
9Vaxcyte Inc(PCVX)306,047$17.8M3.49%
10Enliven Therapeutics Inc(ELVN)329,006$16.7M3.28%
Cap SizePrev %Curr %Change
Small Cap56.62%53.72%-2.9%
Mid Cap32.31%32.11%-0.2%
Micro Cap9.85%9.37%-0.48%
Unclassified1.22%4.8%+3.58%
Closed
8
Increased
1
Decreased
16
Unchanged